{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:20:26Z","timestamp":1780327226121,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"DOI":"10.1186\/1477-7827-1-70","type":"journal-article","created":{"date-parts":[[2003,11,13]],"date-time":"2003-11-13T07:19:13Z","timestamp":1068707953000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Ovarian surface epithelium: family history and early events in ovarian cancer"],"prefix":"10.1186","volume":"1","author":[{"given":"Alice ST","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Auersperg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2003,10,7]]},"reference":[{"key":"70_CR1","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, Loman N, Olsson H, Johannsson O, Borg A, et al.: Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies. Am J Hum Genet. 2003, 72: 1117-1130. 10.1086\/375033.","journal-title":"Am J Hum Genet"},{"key":"70_CR2","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1006\/gyno.2002.6674","volume":"88","author":"J Boyd","year":"2003","unstructured":"Boyd J: Hereditary ovarian cancer: What we know. Gynecol Oncol. 2003, 88: S8-S10. 10.1006\/gyno.2002.6674.","journal-title":"Gynecol Oncol"},{"key":"70_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/ng1193-279","volume":"5","author":"A Lindblom","year":"1993","unstructured":"Lindblom A, Tannergard P, Werelius B, Nordenskjold M: Genetic mapping of a second locus predisposing to human nonpolyposis colorectal cancer. Nat Genet. 1993, 5: 279-282.","journal-title":"Nat Genet"},{"key":"70_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0300-9084(01)01363-3","volume":"84","author":"HT Lynch","year":"2002","unstructured":"Lynch HT, Lynch JF: Hereditary cancer: family history, diagnosis, molecular genetics, ecogenetics, and management strategies. Biochimie. 2002, 84: 3-17. 10.1016\/S0300-9084(01)01363-3.","journal-title":"Biochimie"},{"key":"70_CR5","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1126\/science.8484120","volume":"260","author":"P Peltomaki","year":"1993","unstructured":"Peltomaki P, Aaltonen L, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Green JS, Jass JR, Weber JL, Weber FS, et al.: Genetic mapping of a locus predisposing to human colorectal cancer. Science. 1993, 260: 810-812.","journal-title":"Science"},{"key":"70_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1126\/science.7545954","volume":"266","author":"Y Miki","year":"1994","unstructured":"Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994, 266: 66-71.","journal-title":"Science"},{"key":"70_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/ng0396-333","volume":"12","author":"SV Tavtigian","year":"1996","unstructured":"Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, et al.: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996, 12: 333-337.","journal-title":"Nat Genet"},{"key":"70_CR8","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/hmg\/10.7.705","volume":"10","author":"PL Welcsh","year":"2001","unstructured":"Welcsh PL, King MC: BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet. 2001, 10: 705-713. 10.1093\/hmg\/10.7.705.","journal-title":"Hum Mol Genet"},{"key":"70_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1210\/er.22.2.255","volume":"22","author":"N Auersperg","year":"2001","unstructured":"Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC: Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev. 2001, 22: 255-88. 10.1210\/er.22.2.255.","journal-title":"Endocr Rev"},{"key":"70_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/1097-0142(19840701)54:1<1::AID-CNCR2820540102>3.0.CO;2-9","volume":"54","author":"SB Gusberg","year":"1984","unstructured":"Gusberg SB, Deligdisch L: Ovarian dysplasia. A study of identical twins. Cancer. 1984, 54: 1-4.","journal-title":"Cancer"},{"key":"70_CR11","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1002\/1097-0142(19890215)63:4<748::AID-CNCR2820630424>3.0.CO;2-8","volume":"63","author":"L Deligdisch","year":"1989","unstructured":"Deligdisch L, Gil J: Characterization of ovarian dysplasia by interactive morphometry. Cancer. 1989, 63: 748-755.","journal-title":"Cancer"},{"key":"70_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0090-8258(90)90075-V","volume":"38","author":"SC Plaxe","year":"1990","unstructured":"Plaxe SC, Deligdisch L, Dottino PR, Cohen CJ: Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma. Gynecol Oncol. 1990, 38: 367-372.","journal-title":"Gynecol Oncol"},{"key":"70_CR13","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1093\/jnci\/88.24.1810","volume":"88","author":"H Salazar","year":"1996","unstructured":"Salazar H, Godwin AK, Daly MB, Laub PB, Hogan WM, Rosenblum N, Boente MP, Lynch HT, Hamilton TC: Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst. 1996, 88: 1810-20.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0046-8177(99)90269-1","volume":"30","author":"BA Werness","year":"1999","unstructured":"Werness BA, Afify AM, Bielat KL, Eltabbakh GH, Piver MS, Paterson JM: Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer. Hum Pathol. 1999, 30: 151-157.","journal-title":"Hum Pathol"},{"key":"70_CR15","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T","volume":"89","author":"RR Barakat","year":"2000","unstructured":"Barakat RR, Federici MG, Saigo PE, Robson ME, Offit K, Boyd J: Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes. Cancer. 2000, 89: 383-390. 10.1002\/1097-0142(20000715)89:2<383::AID-CNCR25>3.0.CO;2-T.","journal-title":"Cancer"},{"key":"70_CR16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1097\/00004347-199904000-00009","volume":"18","author":"ME Sherman","year":"1999","unstructured":"Sherman ME, Lee JS, Burks RT, Struewing JP, Kurman RJ, Hartge P: Histopathologic features of ovaries at increased risk for carcinoma. A case-control analysis. Int J Gynecol Pathol. 1999, 18: 151-7.","journal-title":"Int J Gynecol Pathol"},{"key":"70_CR17","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jnci\/91.7.626","volume":"91","author":"JF Stratton","year":"1999","unstructured":"Stratton JF, Buckley CH, Lowe D, Ponder BA: Comparison of prophylactic oophorectomy specimens from carriers and noncarriers of a BRCA1 or BRCA2 gene mutation. United Kingdom Coordinating Committee on Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group. J Natl Cancer Inst. 1999, 91: 626-628. 10.1093\/jnci\/91.7.626.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR18","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.0.CO;2-I","volume":"86","author":"L Deligdisch","year":"1999","unstructured":"Deligdisch L, Gil J, Kerner H, Wu HS, Beck D, Gershoni-Baruch R: Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations. Cancer. 1999, 86: 1544-1550. 10.1002\/(SICI)1097-0142(19991015)86:8<1544::AID-CNCR22>3.3.CO;2-9.","journal-title":"Cancer"},{"key":"70_CR19","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/00004347-199910000-00008","volume":"18","author":"BA Werness","year":"1999","unstructured":"Werness BA, Afify AM, Eltabbakh GH, Huelsman K, Piver MS, Paterson JM: p53, c-erbB, and Ki-67 expression in ovaries removed prophylactically from women with a family history of ovarian cancer. Int J Gynecol Pathol. 1999, 18: 338-343.","journal-title":"Int J Gynecol Pathol"},{"key":"70_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1097\/00004347-199301000-00008","volume":"12","author":"KR Mittal","year":"1993","unstructured":"Mittal KR, Zeleniuch-Jacquotte A, Cooper JL, Demopoulos RI: Contralateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions. Int J Gynecol Pathol. 1993, 12: 59-63.","journal-title":"Int J Gynecol Pathol"},{"key":"70_CR21","first-page":"181","volume":"82","author":"L Resta","year":"1993","unstructured":"Resta L, Russo S, Colucci GA, Prat J: Morphologic precursors of ovarian epithelial tumors. Obstet Gynecol. 1993, 82: 181-186.","journal-title":"Obstet Gynecol"},{"key":"70_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6","volume":"69","author":"HG Dyck","year":"1996","unstructured":"Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera S, Auersperg N: Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer. 1996, 69: 429-436. 10.1002\/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6.","journal-title":"Int J Cancer"},{"key":"70_CR23","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1007\/s11626-998-0059-0","volume":"34","author":"AST Wong","year":"1998","unstructured":"Wong AST, Leung PC, Maines-Bandiera SL, Auersperg N: Metaplastic changes in cultured human ovarian surface epithelium. In Vitro Cell Dev Biol Anim. 1998, 34: 668-70.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"70_CR24","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/0002-9378(95)90282-1","volume":"173","author":"N Auersperg","year":"1995","unstructured":"Auersperg N, Maines-Bandiera S, Booth JH, Lynch HT, Godwin AK, Hamilton TC: Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. Am J Obstet Gynecol. 1995, 173: 558-565.","journal-title":"Am J Obstet Gynecol"},{"key":"70_CR25","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/(SICI)1097-0215(19990412)81:2<180::AID-IJC3>3.0.CO;2-7","volume":"81","author":"AST Wong","year":"1999","unstructured":"Wong AST, Maines-Bandiera SL, Rosen B, Wheelock MJ, Johnson KR, Leung PC, Roskelley CD, Auersperg N: Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer. 1999, 81: 180-8. 10.1002\/(SICI)1097-0215(19990412)81:2<180::AID-IJC3>3.3.CO;2-Z.","journal-title":"Int J Cancer"},{"key":"70_CR26","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1002\/cncr.2820710209","volume":"71","author":"A Berchuck","year":"1993","unstructured":"Berchuck A, Kohler MF, Boente MP, Rodriguez GC, Whitaker RS, Bast RC: Growth regulation and transformation of ovarian epithelium. Cancer. 1993, 71: 545-551.","journal-title":"Cancer"},{"key":"70_CR27","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1095\/biolreprod49.3.635","volume":"49","author":"HJ Ziltener","year":"1993","unstructured":"Ziltener HJ, Maines-Bandiera S, Schrader JW, Auersperg N: Secretion of bioactive IL-1, IL-6 and colony stimulating factors by human ovarian surface epithelium. Biol Reprod. 1993, 49: 635-641.","journal-title":"Biol Reprod"},{"key":"70_CR28","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1038\/sj.onc.1204253","volume":"20","author":"AST Wong","year":"2001","unstructured":"Wong AST, Pelech SL, Woo MM, Yim G, Rosen B, Ehlen T, Leung PC, Auersperg N: Coexpression of hepatocyte growth factor-Met: an early step in ovarian carcinogenesis?. Oncogene. 2001, 20: 1318-1328. 10.1038\/sj.onc.1204253.","journal-title":"Oncogene"},{"key":"70_CR29","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/gyno.2001.6280","volume":"82","author":"AST Wong","year":"2001","unstructured":"Wong AST, Kim SO, Leung PC, Auersperg N, Pelech SL: Profiling of protein kinases in the neoplastic transformation of human ovarian surface epithelium. Gynecol Oncol. 2001, 82: 305-311. 10.1006\/gyno.2001.6280.","journal-title":"Gynecol Oncol"},{"key":"70_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/5042","volume":"21","author":"L Shayesteh","year":"1999","unstructured":"Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW: PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet. 1999, 21: 99-102. 10.1038\/5042.","journal-title":"Nat Genet"},{"key":"70_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1006\/gyno.1999.5348","volume":"73","author":"PA Kruk","year":"1999","unstructured":"Kruk PA, Godwin AK, Hamilton TC, Auersperg N: Telomeric instability and reduced proliferative potential in ovarian surface epithelial cells from women with a family history of ovarian cancer. Gynecol Oncol. 1999, 73: 229-36. 10.1006\/gyno.1999.5348.","journal-title":"Gynecol Oncol"},{"key":"70_CR32","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/jnci\/93.19.1458","volume":"93","author":"SC Mok","year":"2001","unstructured":"Mok SC, Chao J, Skates S, Wong K, Yiu GK, Muto MG, Berkowitz RS, Cramer DW: Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology. J Natl Cancer Inst. 2001, 93: 1458-1464. 10.1093\/jnci\/93.19.1458.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR33","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/S0140-6736(02)07746-2","volume":"359","author":"EF Petricoin","year":"2002","unstructured":"Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, Mills GB, Simone C, Fishman DA, Kohn EC, Liotta LA: Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002, 359: 572-577. 10.1016\/S0140-6736(02)07746-2.","journal-title":"Lancet"},{"key":"70_CR34","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1093\/jnci\/94.13.990","volume":"94","author":"AA Jazaeri","year":"2002","unstructured":"Jazaeri AA, Yee CJ, Sotiriou C, Brantley KR, Boyd J, Liu ET: Gene expression profiles of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers. J Natl Cancer Inst. 2002, 94: 990-1000. 10.1093\/jnci\/94.13.990.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR35","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/jnci\/94.13.960","volume":"94","author":"IA Hedenfalk","year":"2002","unstructured":"Hedenfalk IA: Gene expression profiling of hereditary and sporadic ovarian cancer reveals unique BRCA1 and BRCA2 signatures. J Natl Cancer Inst. 2002, 94: 960-961. 10.1093\/jnci\/94.13.960.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR36","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1093\/jnci\/94.18.1396","volume":"94","author":"J Hilton","year":"2002","unstructured":"Hilton J, Geisler J, Rathe J, Hattermann-Zogg M, DeYoung B, Buller R: Inactivation of BRCA1 and BRCA2 in ovarian cancer. J Natl Cancer Inst. 2002, 94: 1396-1406. 10.1093\/jnci\/94.18.1396.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR37","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/6029","volume":"21","author":"CA Wilson","year":"1999","unstructured":"Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, et al.: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet. 1999, 21: 236-240. 10.1038\/6029.","journal-title":"Nat Genet"},{"key":"70_CR38","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/gyno.1999.5664","volume":"76","author":"W Zheng","year":"2000","unstructured":"Zheng W, Luo F, Lu JJ, Baltayan A, Press MF, Zhang ZF, Pike MC: Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol. 2000, 76: 294-300. 10.1006\/gyno.1999.5664.","journal-title":"Gynecol Oncol"},{"key":"70_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJM200102223440801","volume":"344","author":"I Hedenfalk","year":"2001","unstructured":"Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R, Meltzer P, Gusterson B, Esteller M, Kallioniemi OP, et al.: Gene-expression profiles in hereditrary breast cancer. N Engl J Med. 2001, 344: 539-548. 10.1056\/NEJM200102223440801.","journal-title":"N Engl J Med"},{"key":"70_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1097\/00004347-200101000-00005","volume":"20","author":"BA Werness","year":"2001","unstructured":"Werness BA, Eltabbakh GH: Familial ovarian cancer and early ovarian cancer: biologic, pathologic, and clinical features. Int J Gynecol Pathol. 2001, 20: 48-63. 10.1097\/00004347-200101000-00005.","journal-title":"Int J Gynecol Pathol"},{"key":"70_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","volume":"21","author":"PA Shaw","year":"2002","unstructured":"Shaw PA, McLaughlin JR, Zweemer RP, Narod SA, Risch H, Verheijen RH, Ryan A, Menko FH, Kenemans P, Jacobs IJ: Histopathologic features of genetically determined ovarian cancer. Int J Gynecol Pathol. 2002, 21: 407-411. 10.1097\/00004347-200210000-00011.","journal-title":"Int J Gynecol Pathol"},{"key":"70_CR42","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ng1295-428","volume":"11","author":"SA Gayther","year":"1995","unstructured":"Gayther SA, Warren W, Mazoyer S, Russell PA, Harrington PA, Chiano M, Seal S, Hamoudi R, van Rensburg EJ, Dunning AM, et al.: Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype-phenotype correlation. Nat Genet. 1995, 11: 428-433.","journal-title":"Nat Genet"},{"key":"70_CR43","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1475-2867-2-7","volume":"2","author":"NC Johnson","year":"2002","unstructured":"Johnson NC, Kruk PA: BRCA1 Zinc RING Finger Domain Disruption Alters Caspase Response in Ovarian Surface Epithelial Cells. Cancer Cell Int. 2002, 2: 7-10.1186\/1475-2867-2-7.","journal-title":"Cancer Cell Int"},{"key":"70_CR44","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/ng0197-103","volume":"15","author":"SA Gayther","year":"1997","unstructured":"Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BA, Stratton MR, Easton D: Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet. 1997, 15: 103-5.","journal-title":"Nat Genet"},{"key":"70_CR45","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/ng0396-309","volume":"12","author":"CM Phelan","year":"1996","unstructured":"Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, et al.: Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet. 1996, 12: 309-11.","journal-title":"Nat Genet"},{"key":"70_CR46","first-page":"259","volume":"60","author":"JN Weitzel","year":"2000","unstructured":"Weitzel JN, Ding S, Larson GP, Nelson RA, Goodman A, Grendys EC, Ball HG, Krontiris TG: The HRAS1 minisatellite locus and risk of ovarian cancer. Cancer Res. 2000, 60: 259-261.","journal-title":"Cancer Res"},{"key":"70_CR47","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1038\/nrc726","volume":"2","author":"SA Narod","year":"2002","unstructured":"Narod SA: Modifiers of risk of hereditary breast and ovarian cancer. Nat Rev Cancer. 2002, 2: 113-123. 10.1038\/nrc726.","journal-title":"Nat Rev Cancer"},{"key":"70_CR48","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/humu.10154","volume":"20","author":"A Liede","year":"2002","unstructured":"Liede A, Narod SA: Hereditary breast and ovarian cancer in Asia: genetic epidemiology of BRCA1 and BRCA2. Hum Mutat. 2002, 20: 413-424. 10.1002\/humu.10154.","journal-title":"Hum Mutat"},{"key":"70_CR49","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S0092-8674(02)01052-8","volume":"111","author":"S Ganesan","year":"2002","unstructured":"Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, et al.: BRCA1 supports XIST RNA concentration on the inactive X chromosome. Cell. 2002, 111: 393-405.","journal-title":"Cell"},{"key":"70_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/jnci\/91.4.339","volume":"91","author":"RE Buller","year":"1999","unstructured":"Buller RE, Sood AK, Lallas T, Buekers T, Skilling JS: Association between nonrandom X-chromosome inactivation and BRCA1 mutation in germline DNA of patients with ovarian cancer. J Natl Cancer Inst. 1999, 91: 339-346. 10.1093\/jnci\/91.4.339.","journal-title":"J Natl Cancer Inst"},{"key":"70_CR51","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/sj.onc.1204073","volume":"20","author":"S Fan","year":"2001","unstructured":"Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, et al.: Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Oncogene. 2001, 20: 77-87. 10.1038\/sj.onc.1204073.","journal-title":"Oncogene"},{"key":"70_CR52","doi-asserted-by":"publisher","first-page":"9587","DOI":"10.1073\/pnas.171174298","volume":"98","author":"L Zheng","year":"2001","unstructured":"Zheng L, Annab LA, Afshari CA, Lee WH, Boyer TG: BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor. Proc Natl Acad Sci U S A. 2001, 98: 9587-92. 10.1073\/pnas.171174298.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"70_CR53","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1093\/humupd\/7.3.273","volume":"7","author":"JG Liehr","year":"2001","unstructured":"Liehr JG: Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development. Hum Reprod Update. 2001, 7: 273-81. 10.1093\/humupd\/7.3.273.","journal-title":"Hum Reprod Update"},{"key":"70_CR54","first-page":"5946","volume":"60","author":"JJ Park","year":"2000","unstructured":"Park JJ, Irvine RA, Buchanan G, Koh SS, Park JM, Tilley WD, Stallcup MR, Press MF, Coetzee GA: Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor. Cancer Res. 2000, 60: 5946-5949.","journal-title":"Cancer Res"},{"key":"70_CR55","first-page":"908","volume":"61","author":"DA Levine","year":"2001","unstructured":"Levine DA, Boyd J: The androgen receptor and genetic susceptibility to ovarian cancer: results from a case series. Cancer Res. 2001, 61: 908-911.","journal-title":"Cancer Res"},{"key":"70_CR56","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/S0168-9525(01)02451-9","volume":"17","author":"SG Brodie","year":"2001","unstructured":"Brodie SG, Deng CX: BRCA1-associated tumorigenesis: what have we learned from knockout mice?. Trends Genet. 2001, 17: S18-22. 10.1016\/S0168-9525(01)02451-9.","journal-title":"Trends Genet"},{"key":"70_CR57","first-page":"3461","volume":"60","author":"LM Bennett","year":"2000","unstructured":"Bennett LM, McAllister KA, Malphurs J, Ward T, Collins NK, Seely JC, Gowen LC, Koller BH, Davis BJ, Wiseman RW: Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol. Cancer Res. 2000, 60: 3461-3469.","journal-title":"Cancer Res"},{"key":"70_CR58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/8743","volume":"22","author":"X Xu","year":"2001","unstructured":"Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX: Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumor formation. Nat Genet. 2001, 22: 37-43.","journal-title":"Nat Genet"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7827-1-70.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T15:25:02Z","timestamp":1726241102000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/1477-7827-1-70"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,7]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2003,12]]}},"alternative-id":["70"],"URL":"https:\/\/doi.org\/10.1186\/1477-7827-1-70","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,7]]},"assertion":[{"value":"5 July 2003","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2003","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2003","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"70"}}